Private Advisory Group’s Co-Diagnostics CODX Stock Holding History

Private Advisory Group’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$122K	Sell	39,387 -2,000	-5%	-$6.15K	0.01%	295
2026 Q1	$77K	Buy	41,387 +1,999	+5%	+$6.83K	0.01%	275
2025 Q4	$199K	Hold	39,388	–	–	0.02%	247
2025 Q3	$406K	Hold	39,388	–	–	0.03%	166
2025 Q2	$331K	Hold	39,388	–	–	0.03%	174
2025 Q1	$366K	Hold	39,388	–	–	0.04%	155
2024 Q4	$886K	Buy	+39,388	New	+$1.24M	0.1%	126

Other funds holding CODX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Private Advisory Group's CODX Position: Q2 2026 in Review

Private Advisory Group reduced its Co-Diagnostics (CODX) stake by 4.8% in Q2 2026, selling an estimated $6.15K and leaving 39,387 shares worth $122K. The position accounts for 0.01% of the portfolio, ranked #295.

Private Advisory Group first reported a position in CODX in Q4 2024 and has held it in 7 quarters since. The position peaked at $886K in Q4 2024. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

Private Advisory Group held 39,387 shares of Co-Diagnostics worth $122K as of Q2 2026.
Private Advisory Group sold 2,000 Co-Diagnostics shares in Q2 2026, an estimated $6.15K.
Co-Diagnostics made up 0.01% of Private Advisory Group's portfolio in Q2 2026, its #295 holding.
Private Advisory Group first reported a position in Co-Diagnostics in Q4 2024 and has held it in 7 quarters since.
Private Advisory Group's Co-Diagnostics position peaked at $886K in Q4 2024.
24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Private Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.